US Waives Import Tariffs on Essential Specialty Drugs From India and Other Nations

The United States government issued tariff waivers on specific specialty and lifesaving pharmaceutical products imported from 20 partner nations, prominently including India. The waiver addresses growing domestic drug shortages and rising healthcare costs in the US market. The policy reinforces India's position as a reliable supplier of cost effective, high quality specialty medicines to Western healthcare systems.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.